These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8941025

  • 1. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.
    Chen S, Chou WH, Blouin RA, Mao Z, Humphries LL, Meek QC, Neill JR, Martin WL, Hays LR, Wedlund PJ.
    Clin Pharmacol Ther; 1996 Nov; 60(5):522-34. PubMed ID: 8941025
    [Abstract] [Full Text] [Related]

  • 2. CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.
    Rau T, Wohlleben G, Wuttke H, Thuerauf N, Lunkenheimer J, Lanczik M, Eschenhagen T.
    Clin Pharmacol Ther; 2004 May; 75(5):386-93. PubMed ID: 15116051
    [Abstract] [Full Text] [Related]

  • 3. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
    Arneth B, Shams M, Hiemke C, Härtter S.
    Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
    [Abstract] [Full Text] [Related]

  • 4. [Assessment of CYP2D6 activity as a form of optimizing antidepressant therapy].
    Szewczuk-Bogusławska M, Grzesiak M, Beszłej JA, Kiejna A.
    Psychiatr Pol; 2004 Aug; 38(6):1093-104. PubMed ID: 15779673
    [Abstract] [Full Text] [Related]

  • 5. Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate.
    McConnachie L, Bodor M, Kowdley K, Levy A, Tung B, Thummel K, Phillips B, Bajpai M, Chi V, Esmay JD, Shen DD, Ho RJ.
    Clin Pharmacol Ther; 2004 Apr; 75(4):282-97. PubMed ID: 15060507
    [Abstract] [Full Text] [Related]

  • 6. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P, Cáceres MC, Pozo-Guisado E, Wong ML, Licinio J, Llerena A.
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [Abstract] [Full Text] [Related]

  • 7. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P, Cáceres M, Pozo-Guisado E, Wong ML, Licinio J, Llerena A.
    Biotechniques; 2005 Oct; 39(10 Suppl):S571-4. PubMed ID: 18957039
    [Abstract] [Full Text] [Related]

  • 8. Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.
    Wuttke H, Rau T, Heide R, Bergmann K, Böhm M, Weil J, Werner D, Eschenhagen T.
    Clin Pharmacol Ther; 2002 Oct; 72(4):429-37. PubMed ID: 12386645
    [Abstract] [Full Text] [Related]

  • 9. [Retrospective assessment of the antidepressants tolerance in the group of patients with diagnosis of depression and different CYP2D6 genotype].
    Grzesiak M, Beszłej A, Lebioda A, Jonkisz A, Dobosz T, Kiejna A.
    Psychiatr Pol; 2003 Oct; 37(3):433-44. PubMed ID: 13677973
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study.
    Mulder H, Heerdink ER, van Iersel EE, Wilmink FW, Egberts AC.
    Ann Pharmacother; 2007 Mar; 41(3):408-13. PubMed ID: 17341534
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
    Ingelman-Sundberg M.
    Pharmacogenomics J; 2005 Mar; 5(1):6-13. PubMed ID: 15492763
    [Abstract] [Full Text] [Related]

  • 12. Doxepin inhibits CYP2D6 activity in vivo.
    Szewczuk-Bogusławska M, Kiejna A, Beszłej JA, Orzechowska-Juzwenko K, Milejski P.
    Pol J Pharmacol; 2004 Mar; 56(4):491-4. PubMed ID: 15520506
    [Abstract] [Full Text] [Related]

  • 13. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK, Zalar B, Breskvar K, Dolzan V.
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [Abstract] [Full Text] [Related]

  • 14. The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.
    Brockmöller J, Kirchheiner J, Schmider J, Walter S, Sachse C, Müller-Oerlinghausen B, Roots I.
    Clin Pharmacol Ther; 2002 Oct; 72(4):438-52. PubMed ID: 12386646
    [Abstract] [Full Text] [Related]

  • 15. The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
    Li H, Feng L, Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Li J, Xie Y.
    Acta Oncol; 2006 Oct; 45(5):597-601. PubMed ID: 16864175
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I, Beitelshees AL, Gaedigk A, Walker JR, Pauly DF, Eberst K, Leeder JS, Phillips MS, Gelfand CA, Johnson JA.
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [Abstract] [Full Text] [Related]

  • 17. Characterization of cytochrome P450 2D6 alleles using the Invader system.
    Nevilie M, Selzer R, Aizenstein B, Maguire M, Hogan K, Walton R, Welsh K, Neri B, de Arruda M.
    Biotechniques; 2002 Jun; Suppl():34-8, 40-3. PubMed ID: 12083395
    [Abstract] [Full Text] [Related]

  • 18. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
    Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM.
    Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
    [Abstract] [Full Text] [Related]

  • 19. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL, Bagli M, Krauss H, Müller DJ, Schulze TG, Fangerau H, Ludwig M, Barkow K, Held T, Heun R, Maier W, Rietschel M, Rao ML.
    Pharmacopsychiatry; 2003 Dec; 36(2):73-8. PubMed ID: 12734765
    [Abstract] [Full Text] [Related]

  • 20. Cytochrome P450 2D6 polymorphism and character traits.
    Suzuki E, Kitao Y, Ono Y, Iijima Y, Inada T.
    Psychiatr Genet; 2003 Jun; 13(2):111-3. PubMed ID: 12782969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.